In an American Arbitration Association (AAA) dispute over early-stage drug candidates in a development agreement between two biopharmaceutical companies, CRA consultants quantified damages associated with the alleged breach of the agreement. Dr. Gregory K. Bell submitted an expert report quantifying actual loss damages and unjust enrichment and provided deposition and hearing testimony to support the damages assessment.
Who bore the tariff burden? Economics of IEEPA refund disputes
The refund question sits at the intersection of customs procedure, administrative law, but also economics, and resolution will likely vary significantly across...